- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jennifer Graff on Using Real-World Evidence to Deliver High-Quality Care
Real-world evidence helps to inform high-quality care in a number of different ways, and health information technology has really improved the quality and the caliber of real-world data available, explained Jennifer Graff, PharmD, vice president of comparative effectiveness research, National Pharmaceutical Council.
Real-world evidence helps to inform high-quality care in a number of different ways, explained Jennifer Graff, PharmD, vice president of comparative effectiveness research, National Pharmaceutical Council.
Transcript
How does real-world evidence help with informing and delivering high-quality care?
Real-world evidence helps to inform high-quality care in a number of different ways. It can help from just understanding what patients are doing. Are they adhering to their medication? It helps us understand what are the best care mechanisms, what are evidence-based care pathways that we need it set up. It helps us understand which patients are most likely to be appropriate for special care management programs, identify patients that are more likely to have better outcomes or worse side effects, and it also allows us to move into value-based payment for value-based contracts. So, real-world evidence is that crux of all the things that we do across the healthcare system.
How has the uptake of health information technology impacted the use of real-world evidence?
Health information technology has really improved the quality and the caliber of real-world data that was available. Previously, it was just based upon claims. Now, it’s based upon much richer clinical data from electronic health records, mobile apps, and other sources. So, by understanding all of this, we have much more granularity to understand how patients are doing and what works best for them.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
